IP Library Granted Patent US 9,173,823
Granted Patent B2
US 9,173,823 · App. 13/380,768 · Granted Nov 3, 2015

Preparation for sun protection

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,173,823
App. No.
13/380,768
Granted
Nov 3, 2015
Kind
B2
Abstract

The invention relates to the use of norbixin and an urucum extract enriched in bixin and/or norbixin as a food. The invention also provides a food preparation comprising norbixin, bixin or an extract comprising at least bixin or norbixin, the preparation being intended to be administered orally, for the protection of mammalian skin against UV-radiation.

Claims (19)

1. A method of providing an intracellular penetration protection against ultraviolet radiation comprising the step of orally administering a first molecule of formula (I) with R═CH 3 to prevent damage caused by exposure to ultraviolet radiation on mammalian skin at a daily dose between 5 mg and 100 mg

2. The method according to claim 1 , further comprising the step of mixing the first molecule with a second molecule of formula (I) with R═H.

3. The method according to claim 1 , further comprising the step of administering the first molecule at a daily dose of 35 mg.

4. The method according to claim 2 , further comprising the step of administering the second molecule at a daily dose between 5 mg and 100 mg.

5. A method of providing an intracellular penetration protection against ultraviolet radiation comprising the step of orally administering a first molecule of formula (I) with R═H to prevent damage caused by exposure to ultraviolet radiation on mammalian skin at a daily dose between 5 mg and 100 mg

6. The method according to claim 5 , further comprising the step of mixing the first molecule with a second molecule of formula (I) with R═CH 3 .

7. The method according to claim 5 , further comprising the step of enriching an urucum extract in the first molecule of formula (I) with R═H, to prevent damage caused by exposure to ultraviolet radiation on the skin of mammals.

8. The method according to claim 7 , further comprising the step of enriching the extract with a second molecule of formula (I) with R═CH 3 .

9. Medicinal preparation to be orally administered for the intracellular penetration protection of mammalian skin against UV radiation according to claim 5 , comprising, in an acceptable carrier to be swallowed, the first molecule of formula (I) with R═H at a minimum rate of 0.001% by weight of the molecule to a maximum dose of 92% by weight of said molecule.

10. The preparation according to claim 9 , further comprising a second molecule of formula (I) with R═CH 3 .

11. The method according to claim 1 , further comprising the step of enriching an urucum extract in the first molecule of formula (I) with R═CH 3 , to prevent damage caused by exposure to ultraviolet radiation on mammalian skin.

12. The method according to claim 11 , further comprising the step of enriching the extract with a second molecule of formula (I) with R═H.

13. The method according to claim 11 , wherein the extract contains between 2% and 92% by weight of the first molecule.

14. The method according to claim 12 , wherein the extract contains between 2% and 92% by weight of the second molecule.

15. Preparation to be orally administered, for the intracellular penetration protection of mammalian skin against UV radiation according to claim 1 , comprising, in an acceptable carrier to be swallowed, the first molecule of formula (I) with R═CH 3 at a minimum rate of 0.001% by weight of the molecule to a maximum dose of 92% by weight of said molecule.

16. The preparation according to claim 15 , further comprising a second molecule of formula (I) with R═H.

17. Preparation according to claim 15 , including a minimum dose of 0.001% by weight of the second molecule to a maximum dose of 92% by weight of said second molecule.

18. Preparation according to claim 15 , wherein said preparation being a drug.

19. Preparation according to claim 15 , wherein said preparation being a dietary supplement or food.

Assignments (2)
CHANGE OF NAME Recorded Oct 30, 2016
From: INSTITUT BIOPHYTIS SAS
To: BIOPHYTIS SA
Reel/Frame 040168/0616 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2015
From: LAFONT, RENE; VEILLET, STANISLAS; DIOH, WALY
To: INSTITUT BIOPHYTIS SAS; UNIVERSITE PIERRE ET MARIE CURIE
Reel/Frame 036070/0213 →